Showing results (171-180 of 226) with videos related to
Sort By:
Pageof 23
Genes and Immunity|January 9, 2015
KMT1E-mediated chromatin modifications at the FcγRIIb promoter regulate thymocyte developmentF J Martin, Y Xu, F Lohmann, et al.Plos One|April 16, 2015
The role of lipoprotein-associated phospholipase A2 in a murine model of experimental autoimmune uveoretinitisG L Crawford, J Boldison, D A Copland, et al.Molecular and Cellular Biology|March 31, 2010
Allele-specific H3K79 Di- versus trimethylation distinguishes opposite parental alleles at imprinted regionsPurnima Singh, Li Han, Guillermo E Rivas, et al.Frontiers in Immunology|January 30, 2020
Single Eye mRNA-Seq Reveals Normalisation of the Retinal Microglial Transcriptome Following Acute InflammationOliver H Bell, David A Copland, Amy Ward, et al.Scientific Reports|July 18, 2012
Environmental conditioning in the control of macrophage thrombospondin-1 productionJezrom B Fordham, Jing Hua, Sarah R Morwood, et al.Frontiers in Molecular Neuroscience|January 23, 2015
Gap junction proteins and their role in spinal cord injuryRyan S Tonkin, Yilin Mao, Simon J O'Carroll, et al.Clinical and Experimental Immunology|April 5, 2012
Tumour necrosis factor-mediated macrophage activation in the target organ is critical for clinical manifestation of uveitisT K Khera, D A Copland, J Boldison, et al.Clinical and Experimental Immunology|December 17, 2009
Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitisD A Copland, K Hussain, S Baalasubramanian, et al.Current Drug Targets|November 23, 2012
A key role for connexin hemichannels in spreading ischemic brain injuryJoanne O Davidson, Colin R Green, Laura Bennet, et al.Journal of Cellular and Molecular Medicine|October 20, 2020
Treatment with interleukin-33 is non-toxic and protects retinal pigment epithelium in an ageing model of outer retinal degenerationAlison J Clare, David A Copland, Lindsay B Nicholson, et al.Pageof 23